These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16099147)

  • 1. [Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old].
    Motte J; Pedespan JM; Sevestre M; Chiron C;
    Arch Pediatr; 2005 Oct; 12(10):1533-9. PubMed ID: 16099147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term efficacy and safety of valproate sustained-release formulation in newly diagnosed partial epilepsy VIPe-study. A multicenter observational open-label study.
    Deleu D; Al-Hail H; Mesraoua B; Mahmoud HA;
    Saudi Med J; 2007 Sep; 28(9):1402-7. PubMed ID: 17768469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Valproate sustained release in the treatment of epilepsy].
    Stefan H; Fraunberger B
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chrono impact versus enteric coated valproate in Thai epileptic patients.
    Towanabut S; Tiemkao S; Thammasupapong S; Kijjarak R; Arayawichanon A; Poungvarin N; Sirimaharaj S; Chaisewikul R; Asawavichenjinda T; Maneesuk S; Silpakit O
    J Med Assoc Thai; 2005 Nov; 88(11):1651-9. PubMed ID: 16471115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
    Boggs JG; Preis K
    Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the abrupt switch from solution to modified-release granule formulation of valproate.
    Verrotti A; Nanni G; Agostinelli S; Alleva ET; Aloisi P; Franzoni E; Spalice A; Chiarelli F; Coppola G
    Acta Neurol Scand; 2012 Mar; 125(3):e14-8. PubMed ID: 21707552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
    Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A
    Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in pharmaceutical development presentation with improved pharmacokinetics: a new formulation for valproate.
    Genton P
    Acta Neurol Scand Suppl; 2005; 182():26-32. PubMed ID: 16359430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate.
    Rinnerthaler M; Luef G; Mueller J; Seppi K; Wissel J; Trinka E; Bauer G; Poewe W
    Epilepsia; 2005 Feb; 46(2):320-3. PubMed ID: 15679514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate for epilepsy in rural China: an efficacy and safety assessment in primary care.
    Wang W; Wu J; Li S; Ru X; Zheng J; Zhu S; Sander JW
    Epilepsy Res; 2012 Dec; 102(3):201-5. PubMed ID: 22809651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of newly diagnosed epileptic crises. A French experience].
    Groupe CAROLE (Coordination Active du Réseau Observatoire Longitudinal de l'Epilepsie)
    Rev Neurol (Paris); 2001 Dec; 157(12):1500-12. PubMed ID: 11924446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine.
    Cansu A; Serdaroglu A; Biberoglu G; Tumer L; Hirfanoglu TL; Ezgu FS; Hasanoglu A
    Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study.
    Attilakos A; Katsarou E; Prassouli A; Mastroyianni S; Voudris K; Fotinou A; Garoufi A
    Clin Neuropharmacol; 2009; 32(1):32-4. PubMed ID: 18978499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy.
    Lyczkowski DA; Pfeifer HH; Ghosh S; Thiele EA
    Epilepsia; 2005 Sep; 46(9):1533-8. PubMed ID: 16146450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sodium valproate (Na VPa) monotherapy in childhood epilepsy ].
    Dulac O; Steru D; Rey E; Arthuis M
    Arch Fr Pediatr; 1982; 39(6):347-52. PubMed ID: 6812534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.